Immune checkpoint inhibitor therapy for advanced, recurrent or metastatic non-small cell lung cancer with low or negative PD-L1 expression. - Trial UMIN000050723
Access comprehensive clinical trial information for UMIN000050723 through Pure Global AI's free database. This phase not specified trial is sponsored by Kobe University and is currently Not yet recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000050723
Not yet recruiting
Trial Details
University Hospital Medical Information Network • UMIN000050723
Immune checkpoint inhibitor therapy for advanced, recurrent or metastatic non-small cell lung cancer with low or negative PD-L1 expression.
Study Focus
Observational
Sponsor & Location
Kobe University
Japan
Timeline & Enrollment
N/A
Mar 28, 2023
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000050723
Non-Device Trial